Progress in human chondrodysplasias: Molecular genetics

Annals of the New York Academy of Sciences

Volumn 785, Issue , 1996, Pages 150-159

  Horton, William A ^a  

^a Shriner's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 10; COLLAGEN TYPE 11; COLLAGEN TYPE 2; MATRIX PROTEIN;

ACHONDROPLASIA; ALLELE; AMINO ACID SUBSTITUTION; BONE DEVELOPMENT; BONE DYSPLASIA; CARTILAGE CELL; CARTILAGE MATRIX; CELL PROLIFERATION; CONFERENCE PAPER; GENE LOCUS; GENE MUTATION; HETEROZYGOTE; HUMAN; MOLECULAR GENETICS; X CHROMOSOME LINKAGE;

EID: 0029743140     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb56253.x     Document Type: Conference Paper

References (44)

1. HORTON, W. A. & J. T. HECHT. 1993. The Chondrodysplasias. Extracellular Matrix and Heritable Disorders of Connective Tissue, P. M. Royce and B. Steinman, Eds.: 641-676. Alan R. Liss. New York.
2. RIMOIN, D. L. & R. S. LACHMAN. 1993. Genetic Disorders of the Osseous Skeleton. McKusick's Heritable Disorders of Connective Tissue, P. Beighton, Ed.: 557-690. Mosby. St. Louis, MO.
3. SPRANGER, J., A. WINTERPACHT & B. ZABEL. 1994. The type II collagenopathies: A spectrum of chondrodysplasias. Eur. J. Pediatr. 153: 56-65.
4. BYERS, P. H. 1994. Molecular genetics of chondrodysplasias, including clues to development, structure, and function. Curr. Opin. Rheumatol. 6: 345-350.
5. COLE, W. G. 1994. Collagen genes: Mutations affecting collagen structure and expression. Prog. Nucleic. Acid Res. Molec. Biol. 47: 29-80.
6. HORTON, W. A. 1995. Molecular genetics of the human chondrodysplasias - 1995. Eur. J. Hum. Genet. 3: 357-373.
7. AHMAD, N., L. ALA-KOKKO, R. KNOWLTON, et al. 1991. Stop codon in the procollagen II gene (COL2A1) in a family with the Stickler syndrome (arthroophthalmopathy). Proc. Natl. Acad. Sci. U.S.A. 88: 6624-6627.
8. AHMAD, N. N., D. M. MCDONALD-MCGINN, E. H. ZACKAI, et al. 1993. A second mutation in the type II procollagen gene (COL2A1) causing Stickler syndrome (arthroophthalmopathy) is also a premature termination codon. Am. J. Hum. Genet. 52: 39-45.
9. BROWN, D. M., B. E. NICHOLS, T. A. WEINGEIST, V. C. SHEFFIELD, A. E. KUMURA & E. M. STONE. 1992. Procollagen II gene mutation in Stickler syndrome. Arch. Ophthalmol. 110: 1589-1593.
10. RITVANIEMI, P., J. HYLAND, J. IGNATIUS, K. I. KIVIRIKKO & D. J. PROCKOP. 1993. A fourth example suggests that premature termination codons in the COL2A1 gene are a common cause of the Stickler syndrome: Analysis of COL2A1 gene by denaturing gradient gel electrophoresis. Genomics 17: 218-221.
11. BROWN, D. M., K. VANDENBURGH, S. WEINGEIST, V. C. SHEFFIELD & E. M. STONE 1995. Novel frameshift mutations in the procollagen 2 gene (COL2A1) associated with Stickler syndrome (hereditary arthro-ophthalmopathy). Hum. Molec. Genet. 4: 141-142.
12. VIKKULA, M., E. MARIMAN, V. LUI, et al. 1995. Autosomal dominant and recessive osteochondrodysplasias associated with the COL11A2 locus. Cell 80: 431-437.
13. WARMAN, M. L., M. ABBOTT, S. S. APTE, et al. 1993. A type X collagen mutation causes Schmid metaphyseal chondrodysplasia. Nat. Genet. 5: 79-82.
14. WALLIS, G. A., B. RASH, W. A. SWEETMAN, et al. 1994. Amino acid substitutions of conserved residues in the carboxylterminal domain of the alpha 1 (X) chain of type X collagen occur in two unrelated families with metaphyseal chondrodysplasia type Schmid. Am. J. Hum. Genet. 54: 169-178.
15. DHARMAVARAM, R. M., M. A. ELDERSON, M. PENG, et al. 1994. Identification of a mutation in type X collagen in a family with Schmid metaphyseal chondrodysplasia. Hum. Molec. Genet. 3: 507-509.
16. MCINTOSH, I., M. H. ABBOTT, M. L. WARMAN, B. R. OLSEN & C. A. FRANCOMANO. 1994. Additional mutations of type X collagen confirm COLIOAI as the Schmid metaphyseal chondrodysplasia locus. Hum. Mol. Genet. 3: 303-307.
17. CHAN, D., W. G. COLE, J. G. ROGERS & J. F. BATEMAN. 1995. Type X collagen multimer assembly in vitro is prevented by a Gly618 to Val mutation in the alpha 1(X) NCl domain resulting in Schmid metaphyseal chondrodysplasia. J. Biol. Chem. 270: 4558-4562.
18. MCINTOSH, I., M. H. ABBOTT & C. A. FRANCOMANO. 1995. Concentration of mutations causing Schmid metaphyseal chondrodysplasia in the C-terminal noncollagenous domain of type X collagen. Hum. Mutat. 5: 121-125.
19. SHIANG, R., L. M. THOMPSON, Y.-Z. ZHU, et al. 1994. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78: 335-342.
20. ROUSSEAU, F., J. BONAVENTURE, L. LEGEAL-MALLET, et al. 1995. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371: 252-254.
21. BELLUS, G., T. HEFFERON, R. ORTIZ DE LUNA, et al. 1995. Achondroplasia is defined by recurrent G380R mutations in FGFR3. Am. J. Hum. Genet. 56: 368-373.
22. SPRANGER, J. & P. MAROTEAUX. 1995. The lethal osteochondrodysplasias. Adv. Hum. Genet. 19: 1-103.
23. TAVORMINA, P., R. SHIANG, L. THOMPSON, et al. 1995. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat. Genet. 9: 321-328.
24. ROUSSEAU, F., P. SAUGIER, M. LE MERRER, et al. 1995. Stop codon FGFR3 mutations in thanatophoric dysplasia type I. Nature Genet. Nat. Genet. 10: 11-12.
25. BELLUS, G. A., I. MCINTOSH, E. A. SMITH, et al. 1995. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat. Genet. 10: 357-359.
26. MUENKE, M. & U. SCHELL. 1995. Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trend Genet. 11: 308-313.
27. WILKIE, A., G. MORISS-KAY, E. JONES & J. HEATH. 1995. Functions of fibroblast growth factors and their receptors. Curr. Biol. 5: 500-507.
28. JOHNSON, D. E. & L. T. LEWIS. 1993. Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60: 1-41.
29. HECHT, J. T., L. NELSON, E. CROWDER, et al. 1995. Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia. Nat. Genet. 10: 325-329.
30. BRIGGS, M. D., S. M. G. HOFMAN, L. M. KING, et al. 1995. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nat. Genet. 10: 330-336.
31. NEWTON, G., S. WEREMOWICZ, C. C. MORTON, et al. 1994. Characterization of human and mouse cartilage oligomeric matrix protein. Genomics 24: 435-439.
32. LAWLER, J. 1995. Thrombospondins. Molecular Basis of Thrombosis and Hemostasis, K. A. High and H. R. Roberts, Eds. Marcel Dekker. New York.
33. KNOWLTON, R. G., J. A. CEKLENIAK, D. H. COHN, et al. 1995. High-resolution genetic and physical mapping of multiple epiphyseal dysplasia and pseudoachondroplasia mutations at chromosome 19p13.1-p12. Genomics 28: 513-519.
34. BRIGGS, M. D., H. C. CHOI, M. L. WARMAN, et al. 1994. Genetic mapping of a locus for multiple epiphyseal dysplasia (EDM2) to a region of chromosome 1 containing type IX collagen genes. Am. J. Hum. Genet. 55: 678-684.
35. MURAGAKI, Y., E. C. M. MARIMAN, S. E. C. VAN BEERSUM, et al. 1996. A mutation in the gene encoding the a2 chain of the fibril-associated collagen IX, COL9A2, causés multiple epiphyseal dysplasia (EDM2). Nat. Genet. 12: 103-105.
36. DEERE, M., S. BLANTON, C. SCOTT, L. LANGER, R. PAULI & J. HECHT. 1995. Genetic heterogeneity in multiple epiphyseal dysplasia. Am. J. Hum. Genet. 56: 678-704.
37. HASTBACKA, J., A. DE LA CHAPELLE, M. M. MAHTANI, et al. 1994. The diastrophic dysplasia gene encodes a novel sulfate transporter: Positional cloning by fine-structure linkage disequilibrium mapping. Cell 78: 1073-1087.
38. SUPERTI-FURGA, A., J. HÄSTBACKA, D. H. COHN, et al. 1995. Defective sulfation of proteoglycans in achondrogenesis type IB is caused by mutations in the DTDST gene: The disorder is allelic to diastrophic dysplasia. Am. J. Hum. Genet. Suppl. 57: A48.
39. SCHIPANI, E., K. KRUSE & H. JÜPPNER. 1995. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268: 98-100.
40. AMIZUKA, N., H. WARSHAWSKY, J. E. HENDERSON, D. GOLTZMAN & A. C. KARAPLIS. 1994. Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation. J. Cell Biol. 126: 1611-1123.
41. FRANCO, B., G. MERONI, G. PARENTI, et al. 1995. A cluster of sulfatase genes on Xp22.3: Mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy. Cell 81: 15-25.
42. TOMMERUP, N., W. SCHEMPP, S. PEDERSEN, et al. 1993. Assignment of an autosomal sex reversal locus (SRA1) and campomelic dysplasia (CMPD1) to 17q24.3-q25.1. Nat. Genet. 4: 170-174.
43. FOSTER, J. W., M. A. DOMINGUEZ-STEGLICH, S. GUIOLI, et al. 1994. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SAK-related gene. Nature 372: 525-530.
44. WAGNER, T., J. WIRTH, J. MEYER, et al. 1994. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79: 1111-1120.